Trial Profile
Vildalgliptin and Glucose Variability in Type 2 Diabetes
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2014
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 02 Jul 2014 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
- 07 Jun 2012 New trial record